glp-1 microdosing benefits Let's talk about “microdosing” GLP-1s — because this trend needs to stop. This idea didn't come from science. It came from inexperienced prescribers who saw patients experiencing side effects at therapeutic doses — Microdosing GLP-1s: Safety, Dosage, Side

Least squares mean change from baseline for HbA1c were similar for lixisenatide and sitagliptin (0.7 and 0.7%, respectively)

Either way, you deserve to ask the question

10.1186/s12958-025-01380-5 [DOI] [PMC free article] [PubMed] [Google Scholar] Villalba J

Semaglutide / Cyanocobalamin Injection is a compounded medication that combines semaglutide, a GLP-1 receptor agonist, with cyanocobalamin (vitamin B12) in a single injectable formulation

It is predicted that 693 million adults will be living with diabetes by 2045 (63)

Glucocorticoids are widely prescribed for inflammatory and autoimmune diseases including multiple sclerosis, rheumatoid arthritis, ulcerative colitis, psoriasis and eczema[x] According to WADA, All glucocorticoids are prohibited when administered by oral, intravenous, intramuscular or rectal routes. Read how a cricketer was suspended due to inadvertently ingesting a glucocorticoid that is prohibited in competition